Realistic expectations for treatment success in Alzheimer's disease.
about
Intranasal administration of acetylcholinesterase inhibitors.Should older adults be screened for dementia? It is important to screen for evidence of dementia!A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer's Disease Patients.The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: recommendations of an expert consensus panelLong-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer's disease.Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilitiesThe PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys.Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease.Effect of a high-intensity exercise program on physical function and mental health in nursing home residents with dementia: an assessor blinded randomized controlled trial.Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.Long-term effects of a 12 weeks high-intensity functional exercise program on physical function and mental health in nursing home residents with dementia: a single blinded randomized controlled trial.Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy.Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease.Differences in quality of life in home-dwelling persons and nursing home residents with dementia - a cross-sectional study.Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.Brief cognitive assessment of Alzheimer's disease in advanced stages: Proposal for a Brazilian version of the Short Battery for Severe Impairment (SIB-8).Metabolic Syndrome and Neuroprotection.The cholinergic system in the pathophysiology and treatment of Alzheimer's disease
P2860
Q33393915-A85CD6A1-3B88-44D9-93D0-2D5A4BDA6E06Q33584316-26E10D11-E925-4129-A525-A893957345A4Q33736233-4551D997-0B42-4F0F-97DB-9F5CDC61C46FQ33902284-9385DBE3-3418-42BB-B18C-DA25261F25A1Q34297733-3D760F91-0212-4AF8-B079-916B7CCDEC58Q34746698-69364071-ECC0-42F5-A1D8-3541EB93267CQ34789455-46A3E4AA-B478-4638-8D91-655977B19FBCQ35196195-B8330186-9AF8-44BF-9C60-1E6030984538Q35460043-A1E7E9C0-16AA-4F2C-A391-B29C5914F8A8Q35606780-045617DD-68C1-43D6-8509-12EBFB6EEF13Q35765716-A2928AD1-6768-47A4-BC37-F59A6E1135F5Q35859316-672E05AD-5BB4-436A-A143-E9BA00FF4F70Q36632693-519E2CCC-843D-4441-BC31-61D64B05F245Q37004843-89A8DAEE-B2CC-470F-9BD4-5A4073B4DE6AQ37082318-F78B9E6F-077D-4F04-BA85-364315465599Q37405505-53B7C8B3-29A5-4384-A2C1-031A4741F828Q47103059-BDED8D7B-6CA3-4787-96B8-DC9E2D9E9882Q53687232-8B13B579-9414-4C99-9178-B5C355759BB8Q57177786-901A6E18-40D1-4800-97A8-C06583C37055
P2860
Realistic expectations for treatment success in Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Realistic expectations for treatment success in Alzheimer's disease.
@ast
Realistic expectations for treatment success in Alzheimer's disease.
@en
type
label
Realistic expectations for treatment success in Alzheimer's disease.
@ast
Realistic expectations for treatment success in Alzheimer's disease.
@en
prefLabel
Realistic expectations for treatment success in Alzheimer's disease.
@ast
Realistic expectations for treatment success in Alzheimer's disease.
@en
P2093
P1476
Realistic expectations for treatment success in Alzheimer's disease.
@en
P2093
Banerjee S
Erkinjuntti T
Geldmacher DS
P304
P577
2006-09-01T00:00:00Z